Myrtucommulone B Analogs: Synthesized sEH Inhibitors and Biological Activities

A study by Jia-Rui Sun, published on figshare in April 2026, describes the synthesis and evaluation of novel myrtucommulone B derivatives as soluble epoxide hydrolase (sEH) inhibitors. The dataset, 8.9 MB in size, likely contains results from bioassays measuring sEH inhibition, toxicity, and in vitro/vivo anti-inflammatory and analgesic effects, including data from a murine acute pancreatitis model.

Use Cases

• Training predictive models for sEH inhibitor potency based on compound structure and assay results.
• Analyzing structure-activity relationships for myrtucommulone derivatives.
• Evaluating the correlation between sEH inhibition and in vivo anti-inflammatory/analgesic effects in murine models.
• Identifying candidate compounds for further development as potential therapeutics for acute pancreatitis.

Strengths

• Dataset includes results from both in vitro and in vivo biological assays, as described.
• Data is associated with a specific, peer-reviewed research study on a novel therapeutic target.
• File size is 8.9 MB, suggesting a manageable download and inspection process.

Limitations

• Row count and column-level documentation are unknown, which may limit suitability assessment.
• Description metadata is limited; actual data quality and structure require manual inspection after download.

Provenance

Source

figshare

Collection Method

Likely contains experimental data from chemical synthesis and biological assays described in the associated research.

Time Range

Publication date suggests research was conducted prior to April 2026.

Freshness

Last updated 2026-04-21 19:34:59; freshness should be verified.

Geography

Geographic scope of the research is not specified in the provided metadata.